持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2013/12/03 | 6,130 | 6,150 | 6,090 | 6,090 | -50 | -0.8% | 31,100 |
2013/12/02 | 6,150 | 6,180 | 6,140 | 6,140 | ±0 | ±0% | 17,100 |
2013/11/29 | 6,200 | 6,220 | 6,110 | 6,140 | -90 | -1.4% | 17,700 |
2013/11/28 | 6,250 | 6,250 | 6,190 | 6,230 | +20 | +0.3% | 15,000 |
2013/11/27 | 6,220 | 6,240 | 6,190 | 6,210 | -10 | -0.2% | 14,600 |
2013/11/26 | 6,250 | 6,250 | 6,200 | 6,220 | -10 | -0.2% | 16,100 |
2013/11/25 | 6,170 | 6,230 | 6,130 | 6,230 | +50 | +0.8% | 21,700 |
2013/11/22 | 6,290 | 6,290 | 6,160 | 6,180 | -70 | -1.1% | 22,700 |
2013/11/21 | 6,200 | 6,250 | 6,170 | 6,250 | +90 | +1.5% | 27,500 |
2013/11/20 | 6,130 | 6,170 | 6,100 | 6,160 | +40 | +0.7% | 21,400 |
2013/11/19 | 6,130 | 6,180 | 6,090 | 6,120 | -50 | -0.8% | 24,000 |
2013/11/18 | 6,150 | 6,230 | 6,140 | 6,170 | +40 | +0.7% | 19,900 |
2013/11/15 | 6,210 | 6,240 | 6,130 | 6,130 | -50 | -0.8% | 46,700 |
2013/11/14 | 6,130 | 6,230 | 6,110 | 6,180 | +50 | +0.8% | 37,200 |
2013/11/13 | 6,290 | 6,300 | 6,080 | 6,130 | -160 | -2.5% | 53,600 |
2013/11/12 | 6,260 | 6,290 | 6,220 | 6,290 | +20 | +0.3% | 29,000 |
2013/11/11 | 6,240 | 6,280 | 6,140 | 6,270 | +110 | +1.8% | 37,600 |
2013/11/08 | 6,110 | 6,190 | 6,110 | 6,160 | -30 | -0.5% | 16,700 |
2013/11/07 | 6,250 | 6,250 | 6,130 | 6,190 | -70 | -1.1% | 35,700 |
2013/11/06 | 6,090 | 6,300 | 6,090 | 6,260 | +130 | +2.1% | 28,300 |
2013/11/05 | 6,220 | 6,240 | 6,100 | 6,130 | -40 | -0.6% | 32,700 |
2013/11/01 | 6,260 | 6,260 | 6,160 | 6,170 | -60 | -1% | 20,500 |
2013/10/31 | 6,210 | 6,330 | 6,160 | 6,230 | -60 | -1% | 46,300 |
2013/10/30 | 6,210 | 6,320 | 6,210 | 6,290 | +50 | +0.8% | 51,100 |
2013/10/29 | 6,300 | 6,380 | 6,160 | 6,240 | -90 | -1.4% | 60,400 |
2013/10/28 | 6,320 | 6,340 | 6,260 | 6,330 | +80 | +1.3% | 15,400 |
2013/10/25 | 6,330 | 6,330 | 6,230 | 6,250 | -80 | -1.3% | 35,300 |
2013/10/24 | 6,210 | 6,360 | 6,210 | 6,330 | +60 | +1% | 26,000 |
2013/10/23 | 6,330 | 6,390 | 6,250 | 6,270 | -100 | -1.6% | 35,500 |
2013/10/22 | 6,380 | 6,390 | 6,310 | 6,370 | -10 | -0.2% | 23,900 |
2013/10/21 | 6,340 | 6,380 | 6,290 | 6,380 | +40 | +0.6% | 14,400 |
2013/10/18 | 6,330 | 6,370 | 6,270 | 6,340 | +10 | +0.2% | 22,900 |
2013/10/17 | 6,270 | 6,330 | 6,230 | 6,330 | +80 | +1.3% | 29,800 |
2013/10/16 | 6,220 | 6,260 | 6,170 | 6,250 | +40 | +0.6% | 25,000 |
2013/10/15 | 6,230 | 6,300 | 6,190 | 6,210 | +10 | +0.2% | 33,700 |
2013/10/11 | 6,320 | 6,320 | 6,170 | 6,200 | -40 | -0.6% | 32,900 |
2013/10/10 | 6,140 | 6,270 | 6,120 | 6,240 | +80 | +1.3% | 27,000 |
2013/10/09 | 6,030 | 6,180 | 6,030 | 6,160 | +100 | +1.7% | 34,800 |
2013/10/08 | 5,990 | 6,070 | 5,980 | 6,060 | +50 | +0.8% | 26,200 |
2013/10/07 | 5,990 | 6,140 | 5,990 | 6,010 | +30 | +0.5% | 33,500 |
2013/10/04 | 5,990 | 6,070 | 5,910 | 5,980 | -60 | -1% | 27,200 |
2013/10/03 | 5,970 | 6,080 | 5,960 | 6,040 | +100 | +1.7% | 29,400 |
2013/10/02 | 6,280 | 6,290 | 5,890 | 5,940 | -380 | -6% | 53,700 |
2013/10/01 | 6,420 | 6,440 | 6,310 | 6,320 | -110 | -1.7% | 30,400 |
2013/09/30 | 6,540 | 6,540 | 6,330 | 6,430 | -130 | -2% | 34,000 |
2013/09/27 | 6,550 | 6,610 | 6,470 | 6,560 | -20 | -0.3% | 29,300 |
2013/09/26 | 6,580 | 6,650 | 6,450 | 6,580 | +5,264 | +400% | 22,300 |
2013/09/25 | 1,315 | 1,336 | 1,308 | 1,316 | +1 | +0.1% | 70,000 |
2013/09/24 | 1,331 | 1,331 | 1,305 | 1,315 | -21 | -1.6% | 122,000 |
2013/09/20 | 1,336 | 1,346 | 1,331 | 1,336 | ±0 | ±0% | 90,000 |
2801~
2850
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム